3rd Inflammasome Therapeutics Summit -Moving Beyond NLRP3 to Identify Novel Drug Targets

November 29 - December 1, 2022
Boston, MA

Moving Beyond NLRP3 to Identify Novel Drug Targets

Time: 1:30 pm
day: Day 2 - Track A - Afternoon

Moving Beyond NLRP3 to Identify Novel Drug Targets');return false;" target="_blank"> Moving Beyond NLRP3 to Identify Novel Drug Targets');return false;" target="_blank">

OUR CONTACT DETAILS

T: (+1) 617 455 4188
E: info@hansonwade.com

VENUE DETAILS

50 Park Plaza
Boston, MA
02116
United States

ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

LOCATION

SEARCH

Search

ORGANISED BY

Terms & Conditions

Privacy Policy

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.

November 29 - December 1, 2022Boston, MA

Moving Beyond NLRP3 to Identify Novel Drug Targets

OUR CONTACT DETAILS

VENUE DETAILS

ABOUT US

LOCATION

SEARCH

November 29 - December 1, 2022
Boston, MA